144 related articles for article (PubMed ID: 9817291)
1. Monoclonal antibody-based therapies for hematologic malignancies.
Multani PS; Grossbard ML
J Clin Oncol; 1998 Nov; 16(11):3691-710. PubMed ID: 9817291
[TBL] [Abstract][Full Text] [Related]
2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
3. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
[TBL] [Abstract][Full Text] [Related]
4. The history and rationale for monoclonal antibodies in the treatment of hematologic malignancy.
Dillman RO
Curr Pharm Biotechnol; 2001 Dec; 2(4):293-300. PubMed ID: 11762411
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody therapy of lymphoproliferative disorders.
Kuzel TM; Winter JN; Rosen ST; Zimmer AM
Oncology (Williston Park); 1990 Mar; 4(3):77-84; discussion 84, 89-90, 92-3. PubMed ID: 2144449
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment of hematologic malignancies using immunoconjugates.
Palanca-Wessels MC; Press OW
Blood; 2014 Apr; 123(15):2293-301. PubMed ID: 24578502
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies in hematological malignancies: past, present and future.
Tazi I; Nafil H; Mahmal L
J Cancer Res Ther; 2011; 7(4):399-407. PubMed ID: 22269399
[TBL] [Abstract][Full Text] [Related]
8. [Antibody-drug conjugates and their application in the treatment of hematological malignancies].
Lin L; Ding Q; Tang Q; Zhang ZZ; Dai Z; Zhan JB
Yao Xue Xue Bao; 2012 Oct; 47(10):1287-96. PubMed ID: 23289140
[TBL] [Abstract][Full Text] [Related]
9. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
[TBL] [Abstract][Full Text] [Related]
10. Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
Epner EM; Saroya BS; Hasanali ZS; Loughran TP
Exp Hematol; 2016 Mar; 44(3):157-60. PubMed ID: 26802532
[TBL] [Abstract][Full Text] [Related]
11. A review of monoclonal antibody therapies in lymphoma.
Teo EC; Chew Y; Phipps C
Crit Rev Oncol Hematol; 2016 Jan; 97():72-84. PubMed ID: 26318093
[TBL] [Abstract][Full Text] [Related]
12. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
Amadori S; Stasi R
Curr Opin Hematol; 2008 Mar; 15(2):95-100. PubMed ID: 18300754
[TBL] [Abstract][Full Text] [Related]
13. Clinical status of monoclonal antibodies in the treatment of colorectal carcinoma.
Mellstedt H; Frodin JE; Masucci G
Oncology (Williston Park); 1989 Dec; 3(12):25-32; discussion 37-9, 42. PubMed ID: 2701408
[TBL] [Abstract][Full Text] [Related]
14. Future of monoclonal antibodies in the treatment of hematologic malignancies.
Reff ME; Hariharan K; Braslawsky G
Cancer Control; 2002; 9(2):152-66. PubMed ID: 11965235
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain.
Shannon KM; Ring DB; Houston LL; Schaffner V; Naylor J; Torkildson JC; Reid SA; Larrick J
Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody therapy for cancer.
von Mehren M; Adams GP; Weiner LM
Annu Rev Med; 2003; 54():343-69. PubMed ID: 12525678
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-based therapies in cancer: advances and challenges.
Sapra P; Shor B
Pharmacol Ther; 2013 Jun; 138(3):452-69. PubMed ID: 23507041
[TBL] [Abstract][Full Text] [Related]
18. Phase I clinical trial of drug-monoclonal antibody conjugates in patients with advanced colorectal carcinoma: a preliminary report.
Tjandra JJ; Pietersz GA; Teh JG; Cuthbertson AM; Sullivan JR; Penfold C; McKenzie IF; Smyth M
Surgery; 1989 Sep; 106(3):533-45. PubMed ID: 2788931
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of immunotoxins in leukemia and lymphoma.
Winkler U; Barth S; Schnell R; Diehl V; Engert A
Ann Oncol; 1997; 8 Suppl 1():139-46. PubMed ID: 9187448
[TBL] [Abstract][Full Text] [Related]
20. Immunologic advances in monoclonal antibody therapy: implications for oncology nursing.
Karius D; Marriott MA
Oncol Nurs Forum; 1997 Apr; 24(3):483-94; QUIZ 495-6. PubMed ID: 9127361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
